Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,666,667
-
Total 13F shares
-
23,249,530
-
Share change
-
+1,086,878
-
Total reported value
-
$116,251,010
-
Price per share
-
$5.00
-
Number of holders
-
71
-
Value change
-
+$7,348,216
-
Number of buys
-
42
-
Number of sells
-
21
Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q1 2018
As of 31 Mar 2018,
HARVARD BIOSCIENCE INC - Common Stock (HBIO) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,249,530 shares.
The largest 10 holders included
First Light Asset Management, LLC, DIMENSIONAL FUND ADVISORS LP, HEARTLAND ADVISORS INC, BlackRock Inc., VANGUARD GROUP INC, ROYCE & ASSOCIATES LP, SEGALL BRYANT & HAMILL, LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, ACADIAN ASSET MANAGEMENT LLC, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
72
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.